Dental Care Clinics in Driggs, ID Accepting Medicare
5 Dental Care Clinics found. Showing 1 - 5
 Neerings Dental Inc, Dba Teton Valley Dental Center Dentist Medicare: Not Enrolled in Medicare Practice Location: 235 Wallace Ave, Driggs, ID 83422 Phone: 208-354-8181 Fax: 208-354-8182 |
Teton Valley Dental Center Pllc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 235 E. Wallace Ave., Driggs, ID 83442 Phone: 208-354-8181 Fax: 208-354-8182 |
Cottonwood Dental Care, Pa Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 180 S Main St, Suite B2, Driggs, ID 83422 Phone: 208-354-9700 Fax: 208-354-9701 |
Enduradent Pllc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 33 East Harper Ave, Driggs, ID 83422 Phone: 208-521-7888 |
Teton Valley Dental Center Pllc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 235 E. Wallace Ave., Driggs, ID 83422 Phone: 208-354-8181 Fax: 208-354-8182 |
News Archive
Nasdaq issues TLC Vision a noncompliance letter regarding minimum bid price
TLC Vision Corporation (NASDAQ: TLCV) (TSX: TLC) announced today that, on September 16, 2009, it received letters from The Nasdaq Stock Market indicating that, for the last 30 consecutive business days, the Company's common stock has not maintained a minimum value of publicly held shares of $15 million as required by Marketplace Rule 5450(b)(2)(C) or 5450(b)(3)(C) (the "MVPHS Rule") and the bid price of the Company's common stock has closed below the minimum $1.00 per share requirement for continued inclusion under Marketplace Rule 5450(a)(1) (the "Minimum Bid Price Rule").
Delayed childbearing may protect against triple-negative breast cancer
Younger women who wait at least 15 years after their first menstrual period to give birth to their first child may reduce their risk of an aggressive form of breast cancer by up to 60 percent, according to a Fred Hutchinson Cancer Research Center study.
Wilson Therapeutics' WTX101-201 Phase 2 clinical study to be presented at EASL annual meeting
Wilson Therapeutics AB, a development stage biopharmaceutical company, today announced that a poster of the company's ongoing Phase 2 clinical trial for WTX101-201 will be presented at the upcoming annual meeting of the European Association for the Study of the Liver, or the 50th International Liver Congress 2015, taking place in Vienna April 22-26.
TMNG Global and Scientia Advisors partner to offer strategic consulting services for home health sector
TMNG Global a leading provider of professional services to the global communications, digital media, technology, and financial services industries, and Scientia Advisors, a global management consulting firm specializing in healthcare, life science, nutrition and biotechnology, today announced a partnership to offer strategic consulting services for the emerging home health sector.
› Verified 5 days ago